Navigation Links
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
Date:2/8/2010

License will accelerate the development of prostratin—the first in a new class of drugs for the treatment of HIV/AIDS.

(PRWEB) February 8, 2010 --AIDS Research Alliance announced today the signing of a new licensing agreement with Stanford University, transferring exclusive rights of a novel technology developed by Dr. Paul Wender and colleagues of Stanford to AIDS Research Alliance. This new technology (Science, Vol 320, p 649-652, 2 May 2008) will allow AIDS researchers to synthesize the natural compound, prostratin. Early tests conducted at the National Cancer Institute (NCI) and on-going pre-clinical studies conducted by AIDS Research Alliance indicate that prostratin targets latent HIV—the virus not killed by existing anti-HIV therapies. Previously, prostatin had to be collected from natural resources—an expensive and cumbersome process.



“Dr. Wender’s genius removes a major hurdle to the therapeutic development of this promising compound,” said Carolyn H. Carlburg, President & CEO of AIDS Research Alliance. The ability to produce prostratin synthetically will significantly reduce future costs, making prostratin a more viable drug candidate, Carlburg said.

“When used in combination with existing antiretroviral drugs, prostratin may one day help treating physicians eradicate all virus from the body—a feat not yet possible using existing therapies,” stated Dr. Stephen J. Brown, Medical Director at AIDS Research Alliance.

Dr Brown explains: “Current therapies suppress the virus, but they do not completely eradicate virus from the body. Rather, some viral particles lay dormant in pockets or “reservoirs,” avoiding the reach of today’s anti-HIV drugs. When existing treatments are interrupted, the HIV reservoir floods the body with new virus, re-igniting the infection. Thus, no cure for AIDS is possible without emptying the HIV reservoir.”

“AIDS Research Alliance has the only new drug in development that targets the HIV reservoir,” states Dr. Brown. AIDS Research Alliance has been studying how to flush virus from the HIV reservoir for more than a decade, said Dr. Brown.    

If approved by the U.S. Food & Drug Administration (FDA), prostratin would be the first in a new class of drugs and unveil a novel way to treat HIV/AIDS, Carlburg says.    

AIDS Research Alliance on Wikipedia

About AIDS Research Alliance. AIDS Research Alliance is the nation’s only independent, not-for-profit research organization licensed by the National Institutes of Health to develop an anti-HIV drug. AIDS Research Alliance helped to develop about half of current anti-HIV drugs. AIDS Research Alliance conducts research seeking an HIV vaccine and a cure for AIDS. The U.S. Food & Drug Administration conducted a preliminary review of AIDS Research Alliance’s prostratin data in February 2009. Additional pre-clinical studies will continue over the next year.    

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3532854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Marijuana ineffective as an Alzheimers treatment: UBC-Vancouver Coastal Health research
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. Developing a cyberinfrastructure for comparative effectiveness in cancer research
9. Women should be allowed to eat, drink during labor: Queens University researcher
10. Parkinsons disease research uncovers social barrier
11. Fear of Frailty: Research Shows Lack of Activity Threatens Seniors' Independence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology: